Time to Death, Lung Transplant Not Reduced With Co-Trimoxazole in Moderate, Severe IPF
Trimethoprim-sulfamethoxazole therapy did not reduce time to death, lung transplant, or hospitalization in patients with moderate or severe idiopathic pulmonary fibrosis.